Promising new Alzheimer's drugs may be less effective for Black patients
The
two drugs — Leqembi and donanemab — are the first to offer real hope of
slowing the fatal disease for the 6.5 million Americans living
with ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.